CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that on August 10, 2010, the United States District Court for the Eastern District of Pennsylvania granted the Company's motion to dismiss the securities class action litigation filed in August 2009 against the Company and certain of its former officers.
“We are pleased with the Court's ruling and believe that the facts in the case clearly supported the Company's position.”
Joe Capper, President and Chief Executive Officer, stated, "We are pleased with the Court's ruling and believe that the facts in the case clearly supported the Company's position."
Protecting Rare Plants with a Monmouth Scientific Class 2 Biological Safety Cabinet